Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification
Abstract
We previously reported a characterisation of the hepatocellular carcinoma (HCC) immune contexture and described an immune-specific class. We now aim to further delineate the immunogenomic classification of HCC to incorporate features that explain responses/resistance to immunotherapy.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 23, 2022
- Source ID
- 10.1136/gutjnl-2021-325918
Entities
People
- Agavni Mesropian
- Andrew V Uzilov
- Augusto Villanueva
- Carla Montironi
- Daniela Sia
- Elizabeth Harrod
- Enkhbold Chinbold
- Erdenebileg Taivanbaatar
- Florian Castet
- Huan Wang
- Jaclyn Neely
- Jeffrey Anderson
- Jigjidsuren Chinburen
- Josep M. Llovet
- Laura Torrens
- Manel Solé Arqués
- Marc Puigvehí
- Michael Donovan
- Miguel Torres-Martín
- Miho Maeda
- Myron Schwartz
- Patricia Taik
- Philipp K. Haber
- Roser Pinyol
- Sasan Roayaie
- Scott L. Friedman
- Swan Thung
- Vincenzo Mazzaferro
- Wei Qiang Leow
Organizations
- AIRC - The Italian Foundation for Cancer Research
- Agency for Administration of University and Research
- Bristol-Myers Squibb
- Cancer Research UK
- Carlos III Health Institute
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
- Generalitat of Catalonia
- German Research Foundation
- Horizon 2020
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- Samuel Waxman Cancer Research Foundation
- Spanish Association Against Cancer
- United States Department of Defense